Federal contract award
75A50123F33004
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75A50120D00018 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $317.1M |
| Current contract value | $317.1M |
| Potential contract value / ceiling | $317.1M |
| Start date | Aug 22, 2023 |
| Current end date | Aug 21, 2028 |
| Potential end date | Aug 21, 2028 |
| Latest award activity | Oct 28, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 28, 2025 | P00009 | $0 | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE |
| Jun 12, 2025 | P00008 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI NOTIFICATION OF TERMINATION FOR CONVENIENCE (PARTIAL) |
| Jan 15, 2025 | P00007 | $0 | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE |
| Dec 12, 2024 | P00006 | $0 | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE |
| Oct 31, 2024 | P00005 | $0 | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE |
| Sep 23, 2024 | P00004 | $12.4M | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE |
| Jun 25, 2024 | P00003 | $0 | TRI-NEXGEN |
| May 8, 2024 | P00002 | $0 | TRI-NEXGEN |
| Jan 9, 2024 | P00001 | $0 | TRI-NEXGEN |
| Aug 22, 2023 | 0 | $304.7M | CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION |
Estimated positioning window
Aug 21, 2027 – Feb 21, 2028
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2028-08-21 (659 days from calculation)
- +25 points
- 22 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2025-10-28
- +0 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.